Probio | ProBio CDMO | Biologics Platform

GenScript ProBio is a leading global Contract Development and Manufacturing Organization (CDMO) dedicated to the biologics and advanced therapies (GCT - Cell and Gene Therapy) sectors. Operating as a premier MAI CDMO, the company provides comprehensive, end-to-end manufacturing solutions spanning from early-stage drug discovery and cell line development to cGMP-compliant clinical and commercial-scale production.With state-of-the-art facilities that strictly adhere to international regulatory standards (FDA, EMA, NMPA), GenScript ProBio excels across two core technological platforms:Cell and Gene Therapy Platform: A market leader in the production of high-quality plasmid DNA, lentiviral vectors, and adeno-associated viruses (AAV).Biologics Platform: Specialized in the development and manufacturing of monoclonal antibodies (mAbs), recombinant proteins, and emerging modalities like mRNA.Our Mission: To optimize time-to-market, mitigate manufacturing risks, and reduce production costs for biopharmaceutical partners worldwide, effectively transforming scientific innovation into life-saving therapies for patients.